Assignee
GENVEC INC
US80 patents
Top patents by PatentIndex Score
US6113913ASep 5, 2000
Recombinant adenovirus
GENVEC INC192 citations99
US6057155AMay 2, 2000
Targeting adenovirus with use of constrained peptide motifs
GENVEC INC130 citations99
US5965541AOct 12, 1999
Vectors and methods for gene transfer to cells
GENVEC INC163 citations99
US5846782ADec 8, 1998
Targeting adenovirus with use of constrained peptide motifs
GENVEC INC336 citations99
US5801030ASep 1, 1998
Methods and vectors for site-specific recombination
GENVEC INC299 citations99
US5731190AMar 24, 1998
Penton base protein and methods of using same
GENVEC INC123 citations99
US5712136AJan 27, 1998
Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein
GENVEC INC140 citations99
US6455314B1Sep 24, 2002
Alternatively targeted adenovirus
GENVEC INC82 citations98
US5994106ANov 30, 1999
Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
GENVEC INC405 citations98
US5962311AOct 5, 1999
Short-shafted adenoviral fiber and its use
GENVEC INC109 citations98
US5851806ADec 22, 1998
Complementary adenoviral systems and cell lines
GENVEC INC290 citations98
US7195896B2Mar 27, 2007
Complementary adenoviral vector systems and cell lines
GENVEC INC74 citations97
US6482616B1Nov 19, 2002
RCA-free adenoviral vector system and propagation method
GENVEC INC97 citations97
US5559099ASep 24, 1996
Penton base protein and methods of using same
GENVEC INC269 citations97
US6740525B2May 25, 2004
Adenoviral capsid containing chimeric protein IX
GENVEC INC58 citations96
US6677156B2Jan 13, 2004
Non-adenoviral gene product-based complementing cells for adenoviral vectors
GENVEC INC46 citations96
US6660521B2Dec 9, 2003
Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
GENVEC INC73 citations96
US6649407B2Nov 18, 2003
Targeting adenovirus with use of constrained peptide motifs
GENVEC INC31 citations96
US6465253B1Oct 15, 2002
Vectors and methods for gene transfer to cells
GENVEC INC53 citations96
US6329190B1Dec 11, 2001
Targetting adenovirus with use of constrained peptide motifs
GENVEC INC60 citations96
US6225289B1May 1, 2001
Methods and compositions for preserving adenoviral vectors
GENVEC INC128 citations96
US6063627AMay 16, 2000
Methods and vectors for site-specific recombination
GENVEC INC54 citations96
US6383795B1May 7, 2002
Efficient purification of adenovirus
GENVEC INC57 citations94
US6951755B2Oct 4, 2005
Vectors and methods for gene transfer
GENVEC INC20 citations93
US6753321B2Jun 22, 2004
Method of modulating neovascularization
GENVEC INC19 citations93
US6649373B2Nov 18, 2003
Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
GENVEC INC16 citations93
US6514943B2Feb 4, 2003
Method and composition for preserving viruses
GENVEC INC62 citations93
US6225113B1May 1, 2001
Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
GENVEC INC33 citations93
US6821775B1Nov 23, 2004
Viral vector encoding pigment epithelium-derived factor
GENVEC INC24 citations92
US6682929B2Jan 27, 2004
Adenovector complementing cells
GENVEC INC45 citations92
US6475757B2Nov 5, 2002
Plasmids for construction of eukaryotic viral vectors
GENVEC INC23 citations92
US6472176B2Oct 29, 2002
Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof
GENVEC INC31 citations92
US6440944B2Aug 27, 2002
Methods of administering adenoviral vectors
GENVEC INC19 citations92
US6329200B1Dec 11, 2001
Plasmids for construction of eukaryotic viral vectors
GENVEC INC29 citations92
US6586226B2Jul 1, 2003
Efficient purification of adenovirus
GENVEC INC27 citations91
US6168941B1Jan 2, 2001
Method of producing adenoviral vector stocks
GENVEC INC63 citations91
US5965358AOct 12, 1999
Method for assessing the relative purity of viral gene transfer vector stocks
GENVEC INC77 citations91
US6447995B1Sep 10, 2002
Utilizing intrinsic fluorescence to detect adenovirus
GENVEC INC38 citations90
US6440728B1Aug 27, 2002
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
GENVEC INC23 citations90
US10272162B2Apr 30, 2019
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
GENVEC INC8 citations84
US10059962B2Aug 28, 2018
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC5 citations84
US9617560B2Apr 11, 2017
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
GENVEC INC7 citations84
US9790519B2Oct 17, 2017
Modified serotype 28 adenoviral vectors
GENVEC INC8 citations82
US6913927B2Jul 5, 2005
Non-adenoviral gene product-based complementing cells for adenoviral vectors
GENVEC INC5 citations74
US6908762B2Jun 21, 2005
Method of preparing a eukaryotic viral vector
GENVEC INC7 citations74
US6756044B1Jun 29, 2004
Antigenic complexes and methods
GENVEC INC11 citations74
US6573092B1Jun 3, 2003
Method of preparing a eukaryotic viral vector
GENVEC INC10 citations74
US9580476B2Feb 28, 2017
Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
GENVEC INC3 citations73
US9388429B2Jul 12, 2016
Method for propagating adenoviral vectors encoding inhibitory gene products
GENVEC INC3 citations73
US6861229B2Mar 1, 2005
Method of identifying a gene product
GENVEC INC9 citations73
Showing the top 50 of 80 patents by PatentIndex Score.